Literature DB >> 19500729

Alternative 5'-untranslated first exons of the mouse Cyp19A1 (aromatase) gene.

Jenny D Y Chow1, Evan R Simpson, Wah Chin Boon.   

Abstract

The human aromatase gene (CYP19A1) has eleven tissue-specific untranslated first exons, while only three have been described in the mouse Cyp19A1 namely brain-, ovary- and testis-specific exons 1. The present study aims to elucidate the complete structure of the mouse Cyp19A1 gene. We detected aromatase transcripts in mouse bone, aorta, hypothalamus, adipose, gonads and placenta, but not nulliparous mammary fat pad. BestFit algorithm analysis against the human CYP19A1 has identified ten putative first exons upstream of mouse Cyp19A1. Based on these putative sequences, we were able to design specific primers for RT-PCR and detected for the first time, the presence of exons I.4 and I.3 in murine fat and gonads, respectively. These are novel 5'UTRs of mouse Cyp19A1. Using RT-PCR and 5' RACE, we confirmed the expression of exon 1f in the hypothalamus and proximal exon P2 in the ovary. The testis-specific exon 1 begins 217bp further upstream than previously reported. Putative exons 2a, I.5, I.7, I.6 and I.2 were not detected in mouse tissues. Therefore, we showed that mouse Cyp19A1 contains more tissue-specific first exons than previously thought and displays a similar genomic organization to human CYP19A1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19500729     DOI: 10.1016/j.jsbmb.2009.03.010

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  17 in total

Review 1.  Evolutionary origins of the estrogen signaling system: insights from amphioxus.

Authors:  G V Callard; A M Tarrant; A Novillo; P Yacci; L Ciaccia; S Vajda; G-Y Chuang; D Kozakov; S R Greytak; S Sawyer; C Hoover; K A Cotter
Journal:  J Steroid Biochem Mol Biol       Date:  2011-04-14       Impact factor: 4.292

2.  A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse.

Authors:  Jenny D Y Chow; John T Price; Margaret M Bills; Evan R Simpson; Wah Chin Boon
Journal:  Transgenic Res       Date:  2011-05-26       Impact factor: 2.788

Review 3.  Metabolic pathways in obesity-related breast cancer.

Authors:  Kristy A Brown
Journal:  Nat Rev Endocrinol       Date:  2021-04-29       Impact factor: 43.330

Review 4.  Tissue physiology and pathology of aromatase.

Authors:  Carlos Stocco
Journal:  Steroids       Date:  2011-11-13       Impact factor: 2.668

5.  Aromatase promoter I.f is regulated by progesterone receptor in mouse hypothalamic neuronal cell lines.

Authors:  M Bertan Yilmaz; Andrew Wolfe; Hong Zhao; David C Brooks; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2011-07-18       Impact factor: 5.098

6.  Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo.

Authors:  Srilatha Swami; Aruna V Krishnan; Jennifer Y Wang; Kristin Jensen; Lihong Peng; Megan A Albertelli; David Feldman
Journal:  Horm Cancer       Date:  2011-06       Impact factor: 3.869

7.  Aromatase (CYP19) gene variants influence ovarian response to standard gonadotrophin stimulation.

Authors:  Leandros A Lazaros; Elissavet G Hatzi; Nectaria V Xita; Georgios V Makrydimas; Apostolos I Kaponis; Atsushi Takenaka; Ioannis P Kosmas; Nikolaos V Sofikitis; Theodoros I Stefos; Konstantinos A Zikopoulos; Ioannis A Georgiou
Journal:  J Assist Reprod Genet       Date:  2011-11-17       Impact factor: 3.412

8.  Genomic and neural analysis of the estradiol-synthetic pathway in the zebra finch.

Authors:  Sarah E London; David F Clayton
Journal:  BMC Neurosci       Date:  2010-04-01       Impact factor: 3.288

Review 9.  Progesterone signalling in breast cancer: a neglected hormone coming into the limelight.

Authors:  Cathrin Brisken
Journal:  Nat Rev Cancer       Date:  2013-06       Impact factor: 60.716

Review 10.  Aromatase expression and regulation in breast and endometrial cancer.

Authors:  Hong Zhao; Ling Zhou; Anna Junjie Shangguan; Serdar E Bulun
Journal:  J Mol Endocrinol       Date:  2016-04-11       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.